Contineum Therapeutics, Inc. (CTNM) vs Ocugen, Inc. (OCGN)
- Contineum Therapeutics, Inc. CTNM 7.02 −11.14%
- Ocugen, Inc. OCGN 0.78 −3.70%
Contineum Therapeutics, Inc. and Ocugen, Inc. are both Biotechnology companies. Contineum Therapeutics, Inc. and Ocugen, Inc. are of similar size ($297.2M and $275.9M). Contineum Therapeutics, Inc. has the higher net margin (0.00% vs −1,786.3%) and the lower return on invested capital (−1,334.4% vs 0.00%). Across the 12 metrics below, Contineum Therapeutics, Inc. leads on 8 and Ocugen, Inc. on 4.
Valuation
Profitability
| Metric | CTNM | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,504.43%) | 0.00% |
| Net margin | 0.00% | (1,786.27%) | 0.00% |
| Free cash flow margin | 0.00% | (1,332.36%) | 0.00% |
| Return on equity | (28.01%) | 1,211.66% | (56.36%) |
| Return on assets | (26.57%) | (92.03%) | (48.04%) |
| Return on invested capital | (1,334.41%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack